INSIDER · CIK 1915598
Friedl-Naderer Johanna
Chief Commercial Officer at Dyne Therapeutics, Inc. (DYN)
↗2 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$31KSold on the market
1Companies
Sep 8, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 8, 202616:15 | Sep 8, 2026from Sep 4, 2026 | DYNDyne Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $23.42 | −1,085 | 152,897 | -1% | −$25K | ||
| Aug 17, 202616:08 | Aug 13, 2026 | DYNDyne Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $26.28 | −226 | 153,982 | -0% | −$6K |